# Ananda Pharma to Begin Dosing in NHS-Backed CBD Endometriosis Trial > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cbd-endometriosis-trial-nhs-dosing-begins/ > **Published:** 2026-03-04T15:36:48-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:11:45-04:00 > **Clinical Summary:** Explore the NHS-backed CBD endometriosis trial focusing on dosing and pain management for women with endometriosis. --- ✦ New CED Clinical Relevance #68 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PainResearchCBDPolicyDosing Why This Matters Women with endometriosis who are considering CBD as part of their pain management may soon have access to NHS-level clinical trial data to inform conversations with their physicians about safety and dosing. Clinical Summary Endometriosis affects roughly one in ten women of reproductive age and remains chronically undertreated, with many patients cycling through years of hormonal therapies and surgical interventions before achieving meaningful relief. CBD has emerged as a candidate for managing the [chronic pelvic pain](https://cedclinic.com/cannabis-for-chronic-pelvic-pain-self-management/) and inflammatory burden associated with endometriosis, partly through its interactions with the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/), which is increasingly understood to play a role in uterine function and pain signaling. An NHS-backed clinical trial now moving into the dosing phase represents a significant step toward generating the rigorous, controlled evidence that has been largely absent from this space. Dr. Caplan’s Take “The endocannabinoid system is deeply implicated in pelvic pain pathophysiology, and it is long overdue for a properly powered trial to test whether CBD can deliver measurable, reproducible relief for endometriosis patients rather than just anecdote.” Clinical Perspective This NHS-backed trial represents a meaningful step toward understanding CBD’s potential role in endometriosis management, a condition where current pharmacological options remain limited. • The focus on cannabidiol specifically allows for investigation of potential analgesic and anti-inflammatory mechanisms without the psychoactive effects of THC, which may improve patient acceptability and compliance. • Rigorous clinical trial data from a government-backed institution could provide the evidence base needed to inform dosing protocols and patient selection criteria for future therapeutic applications. • The transition from preclinical research to human dosing underscores growing institutional recognition that cannabinoids warrant systematic evaluation in gynecological pain conditions. • Results from this study may help clarify whether endometriosis-related pain and inflammation respond to CBD through endocannabinoid system modulation or other pathways. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Ananda+Pharma+to+Begin+Dosing+in+NHS-Backed+CBD+Endometriosis+Trial+%40drcaplan&url=https%3A%2F%2Fcannabishealthnews.co.uk%2F2026%2F03%2F04%2Fananda-pharma-to-begin-dosing-in-nhs-backed-cbd-endometriosis-trial) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcannabishealthnews.co.uk%2F2026%2F03%2F04%2Fananda-pharma-to-begin-dosing-in-nhs-backed-cbd-endometriosis-trial) [🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Ananda+Pharma+to+Begin+Dosing+in+NHS-Backed+CBD+Endometriosis+Trial+%E2%80%94+via+%40drcaplan.bsky.social+https%3A%2F%2Fcannabishealthnews.co.uk%2F2026%2F03%2F04%2Fananda-pharma-to-begin-dosing-in-nhs-backed-cbd-endometriosis-trial) [📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/) [📝 Read more on Substack](https://substack.com/@doctorapproved) [🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://cannabishealthnews.co.uk/2026/03/04/ananda-pharma-to-begin-dosing-in-nhs-backed-cbd-endometriosis-trial](https://cannabishealthnews.co.uk/2026/03/04/ananda-pharma-to-begin-dosing-in-nhs-backed-cbd-endometriosis-trial) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabinoids Show Promise for Chronic Pain, But Evidence Remains Thin – CED Clinic](https://cedclinic.com/cannabinoid-clinical-evidence-chronic-pain-insights/) Explore the current evidence on cannabinoids for [chronic pain management](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/) and the need for more rigorous [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/). [Read More](https://cedclinic.com/cannabinoid-clinical-evidence-chronic-pain-insights/) [Many studies show the efficacy of cannabis for inflammation. That's important because …](https://cedclinic.com/cannabis-anti-inflammatory-effects-research-clinical-insights/) Review research highlighting cannabis's anti-inflammatory properties relevant to conditions like endometriosis. [Explore Research](https://cedclinic.com/cannabis-anti-inflammatory-effects-research-clinical-insights/) [Exploring Cannabinoids and Their Role in Patient Care – Cannabis News | NUG Magazine](https://cedclinic.com/cannabinoid-therapeutics-clinical-practice-patient-care/) Understand how cannabinoids are being integrated into [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) and their therapeutic potential. [Learn More](https://cedclinic.com/cannabinoid-therapeutics-clinical-practice-patient-care/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).